1. Home
  2. PDS vs PCRX Comparison

PDS vs PCRX Comparison

Compare PDS & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Drilling Corporation

PDS

Precision Drilling Corporation

HOLD

Current Price

$93.93

Market Cap

918.1M

Sector

N/A

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$22.74

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDS
PCRX
Founded
1951
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
918.1M
1.0B
IPO Year
1998
2010

Fundamental Metrics

Financial Performance
Metric
PDS
PCRX
Price
$93.93
$22.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$122.33
$37.20
AVG Volume (30 Days)
122.6K
593.8K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.16
Revenue
N/A
$541,533,000.00
Revenue This Year
$6.09
$6.78
Revenue Next Year
$2.10
$8.54
P/E Ratio
$884.15
$141.88
Revenue Growth
N/A
26.04
52 Week Low
$36.20
$18.80
52 Week High
$103.80
$27.99

Technical Indicators

Market Signals
Indicator
PDS
PCRX
Relative Strength Index (RSI) 50.77 50.06
Support Level $85.27 $22.57
Resistance Level $103.80 $23.94
Average True Range (ATR) 3.83 0.90
MACD -0.87 -0.03
Stochastic Oscillator 25.34 52.38

Price Performance

Historical Comparison
PDS
PCRX

About PDS Precision Drilling Corporation

Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: